Apogee Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 400 | -400 | -400 | -207 |
EBITDA | -77,650 | -64,559 | -72,766 | -62,889 |
EBIT | -78,056 | -64,959 | -73,165 | -63,096 |
Net Income | -69,387 | -65,021 | -66,096 | -55,339 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -62,751 | -54,255 | -62,797 | -52,794 |
Cash | 131,549 | 107,914 | 124,192 | 106,916 |
Basic Shares | 60,690 | 58,773 | 58,428 | 58,195 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,418 | -189 | ||
EBITDA | -284,177 | -216,681 | -74,967 | -39,785 |
EBIT | -285,595 | -216,870 | -83,985 | -64,247 |
Net Income | -255,843 | -182,146 | -83,985 | -39,785 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -232,597 | -172,326 | -74,928 | -16,427 |
Cash | 131,549 | 141,789 | 118,316 | 151,890 |
Basic Shares | 60,690 | 55,193 | 50,655 | 50,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.03 |
2025-09-30 | -$1.11 |
2025-06-30 | -$1.13 |
2025-03-31 | -$0.95 |
